Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does DIVALPROEX Cause Neuroleptic malignant syndrome? 105 Reports in FDA Database

Sharpen Your Memory & Focus Naturally

NeuroZoom — 35 clinically studied ingredients. No stimulants. Pure brain support.

Boost Your Brain

According to the FDA Adverse Event Reporting System (FAERS), 105 reports of Neuroleptic malignant syndrome have been filed in association with DIVALPROEX (Divalproex Sodium). This represents 0.9% of all adverse event reports for DIVALPROEX.

105
Reports of Neuroleptic malignant syndrome with DIVALPROEX
0.9%
of all DIVALPROEX reports
2
Deaths
75
Hospitalizations

How Dangerous Is Neuroleptic malignant syndrome From DIVALPROEX?

Of the 105 reports, 2 (1.9%) resulted in death, 75 (71.4%) required hospitalization, and 27 (25.7%) were considered life-threatening.

Is Neuroleptic malignant syndrome Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for DIVALPROEX. However, 105 reports have been filed with the FAERS database.

What Other Side Effects Does DIVALPROEX Cause?

Drug ineffective (1,121) Seizure (1,095) Off label use (576) Somnolence (545) Drug interaction (540) Nausea (526) Weight increased (509) Tremor (461) Toxicity to various agents (452) Vomiting (436)

What Other Drugs Cause Neuroleptic malignant syndrome?

QUETIAPINE (1,756) OLANZAPINE (1,748) RISPERIDONE (1,258) HALOPERIDOL (1,244) ARIPIPRAZOLE (1,138) CLOZAPINE (899) LITHIUM (506) LORAZEPAM (437) PALIPERIDONE (355) VALPROIC ACID (352)

Which DIVALPROEX Alternatives Have Lower Neuroleptic malignant syndrome Risk?

DIVALPROEX vs DOBUTAMINE DIVALPROEX vs DOBUTAMINE\DOBUTAMINE DIVALPROEX vs DOCETAXEL DIVALPROEX vs DOCETAXEL ANHYDROUS DIVALPROEX vs DOCETAXEL\DOCETAXEL ANHYDROUS

Related Pages

DIVALPROEX Full Profile All Neuroleptic malignant syndrome Reports All Drugs Causing Neuroleptic malignant syndrome DIVALPROEX Demographics